Christopher W. Cutler
Research Subjects
Christopher W. Cutler has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ravi Jotwani
3 shared publications- Anthony M. Iacopino
University of Manitoba, Winnipeg, Manitoba
2 shared publications - Byung-Ock Kim
Professor, Department of Periodontology, School of Dentistry, Chosun University, Gwangju, Republic of Korea
1 shared publication Candy Ross
Baylor College of Dentistry‐TAMUS, PO Box 660677, Dallas, Texas 75266‐0677
1 shared publicationCeleste Abraham
Baylor College of Dentistry‐TAMUS, PO Box 660677, Dallas, Texas 75266‐0677
1 shared publicationEdward A. Shinedling
Departments of Periodontics and Biomedical Sciences, Baylor College of Dentistry, Dallas, TX
1 shared publication
Latest Publications
- 1 August 2003
- Published by Wiley in Journal of Periodontology
- Vol. 74 (8) , 1191-1195
Effects of Enamel Matrix Derivative on Porphyromonas gingivalis
Enamel matrix derivative (EMD) is used during periodontal surgery for the regeneration of periodontal tissue. It consists of the amelogenin fraction of porcine enamel matrix (AMEL) suspended in a vehicle of propylene glycol alginate (PGA). EMD-treated sites appear to heal with less inflammation. It has been suggested that antimicrobial properties of EMD might account for improved healing in vivo. The objectives of this study were: 1) to determine the antibacterial effects of EMD on the periodontal pathogen Porphyromonas gingivalis and 2) to establish the component(s) of EMD that are responsible for this effect. The antimicrobial effects were determined in vitro using the broth dilution assay. P. gingivalis at a starting inoculum of 10(9) colony forming units/ml was treated with EMD, AMEL, and PGA in Hank's balanced salt solution (HBSS) for 1, 3, and 24 hours. The CFU/ml of P. gingivalis recovered on enriched Brucella blood agar was determined at 6 and 10 days. EMD (containing AMEL and PGA) or PGA alone eliminated recoverable CFUs of P. gingivalis. Interestingly, AMEL in HBSS increased recoverable CFUs from 8.62 log CFU/ml to 8.93 log CFU/ml. Further analysis of the dose response at concentrations of 0.3, 3, and 30 mg/ml of AMEL in HBSS revealed that only 30 mg/ml (clinical concentration) increased CFUs of P. gingivalis relative to baseline (from 8.8 log CFU/ml to 9.2 log CFU/ml in 3 hours). Additionally, AMEL was compared to a protein control bovine serum albumin (BSA) to determine whether this effect was unique to AMEL. A marked increase in recoverable CFUs occurred with the AMEL (increasing from 8.8 log CFU/ml to 9.47 log CFU/ml), but not with BSA. EMD possesses antimicrobial properties that can be attributed to the propylene glycol alginate vehicle. The amelogenin fraction of porcine enamel matrix in enamel matrix derivative (i.e., AMEL) is not antibacterial for P. gingivalis and was shown to increase recoverable CFUs.
- 1 August 2003
- Published by Wiley in Journal of Periodontology
- Vol. 74 (8) , 1191-1195
Effects of Enamel Matrix Derivative on Porphyromonas gingivalis
Enamel matrix derivative (EMD) is used during periodontal surgery for the regeneration of periodontal tissue. It consists of the amelogenin fraction of porcine enamel matrix (AMEL) suspended in a vehicle of propylene glycol alginate (PGA). EMD-treated sites appear to heal with less inflammation. It has been suggested that antimicrobial properties of EMD might account for improved healing in vivo. The objectives of this study were: 1) to determine the antibacterial effects of EMD on the periodontal pathogen Porphyromonas gingivalis and 2) to establish the component(s) of EMD that are responsible for this effect. The antimicrobial effects were determined in vitro using the broth dilution assay. P. gingivalis at a starting inoculum of 10(9) colony forming units/ml was treated with EMD, AMEL, and PGA in Hank's balanced salt solution (HBSS) for 1, 3, and 24 hours. The CFU/ml of P. gingivalis recovered on enriched Brucella blood agar was determined at 6 and 10 days. EMD (containing AMEL and PGA) or PGA alone eliminated recoverable CFUs of P. gingivalis. Interestingly, AMEL in HBSS increased recoverable CFUs from 8.62 log CFU/ml to 8.93 log CFU/ml. Further analysis of the dose response at concentrations of 0.3, 3, and 30 mg/ml of AMEL in HBSS revealed that only 30 mg/ml (clinical concentration) increased CFUs of P. gingivalis relative to baseline (from 8.8 log CFU/ml to 9.2 log CFU/ml in 3 hours). Additionally, AMEL was compared to a protein control bovine serum albumin (BSA) to determine whether this effect was unique to AMEL. A marked increase in recoverable CFUs occurred with the AMEL (increasing from 8.8 log CFU/ml to 9.47 log CFU/ml), but not with BSA. EMD possesses antimicrobial properties that can be attributed to the propylene glycol alginate vehicle. The amelogenin fraction of porcine enamel matrix in enamel matrix derivative (i.e., AMEL) is not antibacterial for P. gingivalis and was shown to increase recoverable CFUs.
- 1 February 2000
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 27 (2) , 134-143
Clinical benefits of oral irrigation for periodontitis are related to reduction of pro‐inflammatory cytokine levels and plaque
Background: Although a growing body of evidence indicates that oral irrigation with water has therapeutic benefits in periodontitis, the mechanisms of action have not been elucidated. The aims of this study were: (1) to analyze the effects of oral irrigation (Water Pik® Oral Irrigator) on the clinical signs of adult periodontitis (AP) and on the levels of interleukin‐1β (IL‐β), prostaglandin‐E2 (PGE2), interleukin‐10 (IL‐10) and interferon‐γ (IFN‐γ) in GCF, and (2) to analyze the influence of the periodontitis‐related IL‐1 genotype (IL‐1GT) on these variables.Method: A single‐center, blinded study in otherwise healthy humans (n=52) with localized mild to moderate AP was carried out, using the following groups: group A (n=12), no oral hygiene for 14 days; group B (n=20), routine oral hygiene (ROH) for 14 days; group C (n=20), supra‐gingival oral irrigation plus ROH for 14 days. Group A patients were crossed‐over to group C for 14 days (=day 28) after a professional prophylaxis. Group assignment was randomized by a coin toss, with the exception of group A subjects, who were self‐selected as per recommendations of the internal review board for human subjects. GCF was sampled from 3 study teeth per patient and analyzed for IL‐1β, PGE2, IL‐10 and IFNγ by ELISA on days 0, 7, 14 and 28. Probing pocket depths (PPD), clinical attachment levels (CAL), bleeding on probing (BOP), gingival index (GI) and plaque index (PI) were measured by a calibrated examiner (TWS) on days 0, 14 and 28. Analysis of covariance was performed using SAS 6.12 and Proc Mixed with group and IL‐1GT as the factors and the baseline levels as the covariate, with output being least squares means and least significant difference (LSD). Significant differences were declared if the p‐value for the F‐statistic was 0.05.Results: Oral irrigation plus ROH resulted in a significant reduction in PPD, BOP, GI and PI, as well as IL‐β levels by 7 days and PGE2 levels by 14 days, relative to ROH or no oral hygiene. Interestingly, decreased IL‐1β levels in patients using oral irrigation plus ROH was accompanied by a trend for increased levels of the “anti‐inflammatory” cytokine IL‐10. ROH reduced GI, BOP and PI, and PGE2 levels by 14 days, but had no effect on IL‐1β or IL‐10 levels relative to no oral hygiene. The effects of no oral hygiene were reversed by a prophy followed by oral irrigation plus ROH for 14 days. No clinical differences were evident between IL‐1 GT (+) patients (n=11) and GT (−) patients (n=40), but the former had significantly elevated levels of GCF IL‐10 and borderline increases in IL‐1β (p=0.07).Conclusions: Oral irrigation with water for 14 days had an improved therapeutic benefit for AP over that of routine oral hygiene alone and this improvement was accompanied by a down‐modulation of the pro‐inflammatory cytokine profile in GCF.
- 1 February 2000
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 27 (2) , 134-143
Clinical benefits of oral irrigation for periodontitis are related to reduction of pro‐inflammatory cytokine levels and plaque
Background: Although a growing body of evidence indicates that oral irrigation with water has therapeutic benefits in periodontitis, the mechanisms of action have not been elucidated. The aims of this study were: (1) to analyze the effects of oral irrigation (Water Pik® Oral Irrigator) on the clinical signs of adult periodontitis (AP) and on the levels of interleukin‐1β (IL‐β), prostaglandin‐E2 (PGE2), interleukin‐10 (IL‐10) and interferon‐γ (IFN‐γ) in GCF, and (2) to analyze the influence of the periodontitis‐related IL‐1 genotype (IL‐1GT) on these variables.Method: A single‐center, blinded study in otherwise healthy humans (n=52) with localized mild to moderate AP was carried out, using the following groups: group A (n=12), no oral hygiene for 14 days; group B (n=20), routine oral hygiene (ROH) for 14 days; group C (n=20), supra‐gingival oral irrigation plus ROH for 14 days. Group A patients were crossed‐over to group C for 14 days (=day 28) after a professional prophylaxis. Group assignment was randomized by a coin toss, with the exception of group A subjects, who were self‐selected as per recommendations of the internal review board for human subjects. GCF was sampled from 3 study teeth per patient and analyzed for IL‐1β, PGE2, IL‐10 and IFNγ by ELISA on days 0, 7, 14 and 28. Probing pocket depths (PPD), clinical attachment levels (CAL), bleeding on probing (BOP), gingival index (GI) and plaque index (PI) were measured by a calibrated examiner (TWS) on days 0, 14 and 28. Analysis of covariance was performed using SAS 6.12 and Proc Mixed with group and IL‐1GT as the factors and the baseline levels as the covariate, with output being least squares means and least significant difference (LSD). Significant differences were declared if the p‐value for the F‐statistic was 0.05.Results: Oral irrigation plus ROH resulted in a significant reduction in PPD, BOP, GI and PI, as well as IL‐β levels by 7 days and PGE2 levels by 14 days, relative to ROH or no oral hygiene. Interestingly, decreased IL‐1β levels in patients using oral irrigation plus ROH was accompanied by a trend for increased levels of the “anti‐inflammatory” cytokine IL‐10. ROH reduced GI, BOP and PI, and PGE2 levels by 14 days, but had no effect on IL‐1β or IL‐10 levels relative to no oral hygiene. The effects of no oral hygiene were reversed by a prophy followed by oral irrigation plus ROH for 14 days. No clinical differences were evident between IL‐1 GT (+) patients (n=11) and GT (−) patients (n=40), but the former had significantly elevated levels of GCF IL‐10 and borderline increases in IL‐1β (p=0.07).Conclusions: Oral irrigation with water for 14 days had an improved therapeutic benefit for AP over that of routine oral hygiene alone and this improvement was accompanied by a down‐modulation of the pro‐inflammatory cytokine profile in GCF.
- 1 December 1999
- Published by Wiley in Journal of Periodontology
- Vol. 70 (12) , 1429-1434
Association Between Periodontitis and Hyperlipidemia: Cause or Effect?
Background: Epidemiological studies suggest a relationship between periodontitis and coronary artery disease, but the mechanism has not been established. Recent studies in animals indicate that low dose endotoxin, as in a Gram‐negative infection, can induce hyperlipidemia and myeloid cell hyperactivity. The association between periodontitis, systemic exposure to Porphyromonas gingivalis, lipopolysaccharides (LPS), and hyperlipidemia has not been examined in humans.Methods: Sera were obtained from 26 adult periodontitis patients and 25 healthy control (C) subjects selected from patients and staff. Serum antibodies against Porphyromonas gingivalis and its LPS were analyzed by enzyme‐linked immunosorbent assay (ELISA) and Western blotting, respectively. Serum triglycerides (TG) and cholesterol (CHOL) were assayed by a commercial laboratory. The associations between AP and blood levels of TG, CHOL, and anti‐P. gingivalis whole cells and LPS were examined by logistic regression analysis. Peripheral blood polymorphonuclear leukocytes (PMNs) from 6 healthy fasted donors were incubated with purified TG (0.1 mg/ml) for 2 hours at 37°C, stimulated with 100 ng/ml P. gingivalis LPS, and the release of IL‐1β measured by ELISA.Results: The presence of periodontitis was significantly associated with age (odds ratio = 3.5, P = 0.04), elevated TG levels (odds ratio = 8.6, P = 0.0009), elevated CHOL levels (odds ratio = 7, P = 0.004), elevated ELISA titer (odds ratio = 35, P = 0.003) and reactivity with P. gingivalis LPS (odds ratio = 41, P = 0.001). PMNs from all 6 healthy patients released modest levels of IL‐1β (10 to 60 pg/ml) when stimulated with 100 ng/ml P. gingivalis LPS. Addition of TG resulted in a significant increase (P Conclusions: The results of this study indicate the presence of a significant relationship between periodontitis, hyperlipidemia, and serum antibodies against P. gingivalis LPS that warrants further examination in a larger patient population. Furthermore, these studies indicate that elevated triglycerides are able to modulate IL‐1β production by PMNs stimulated with P. gingivalis LPS. J Periodontol 1999;70:1429‐1434.
- 1 December 1999
- Published by Wiley in Journal of Periodontology
- Vol. 70 (12) , 1429-1434
Association Between Periodontitis and Hyperlipidemia: Cause or Effect?
Background: Epidemiological studies suggest a relationship between periodontitis and coronary artery disease, but the mechanism has not been established. Recent studies in animals indicate that low dose endotoxin, as in a Gram‐negative infection, can induce hyperlipidemia and myeloid cell hyperactivity. The association between periodontitis, systemic exposure to Porphyromonas gingivalis, lipopolysaccharides (LPS), and hyperlipidemia has not been examined in humans.Methods: Sera were obtained from 26 adult periodontitis patients and 25 healthy control (C) subjects selected from patients and staff. Serum antibodies against Porphyromonas gingivalis and its LPS were analyzed by enzyme‐linked immunosorbent assay (ELISA) and Western blotting, respectively. Serum triglycerides (TG) and cholesterol (CHOL) were assayed by a commercial laboratory. The associations between AP and blood levels of TG, CHOL, and anti‐P. gingivalis whole cells and LPS were examined by logistic regression analysis. Peripheral blood polymorphonuclear leukocytes (PMNs) from 6 healthy fasted donors were incubated with purified TG (0.1 mg/ml) for 2 hours at 37°C, stimulated with 100 ng/ml P. gingivalis LPS, and the release of IL‐1β measured by ELISA.Results: The presence of periodontitis was significantly associated with age (odds ratio = 3.5, P = 0.04), elevated TG levels (odds ratio = 8.6, P = 0.0009), elevated CHOL levels (odds ratio = 7, P = 0.004), elevated ELISA titer (odds ratio = 35, P = 0.003) and reactivity with P. gingivalis LPS (odds ratio = 41, P = 0.001). PMNs from all 6 healthy patients released modest levels of IL‐1β (10 to 60 pg/ml) when stimulated with 100 ng/ml P. gingivalis LPS. Addition of TG resulted in a significant increase (P Conclusions: The results of this study indicate the presence of a significant relationship between periodontitis, hyperlipidemia, and serum antibodies against P. gingivalis LPS that warrants further examination in a larger patient population. Furthermore, these studies indicate that elevated triglycerides are able to modulate IL‐1β production by PMNs stimulated with P. gingivalis LPS. J Periodontol 1999;70:1429‐1434.
- 1 November 1999
- Published by Wiley in Journal of Periodontology
- Vol. 70 (11) , 1313-1321
Heightened Gingival Inflammation and Attachment Loss in Type 2 Diabetics With Hyperlipidemia
Background: Our previous studies in diabetic (DB) rats suggest that hyperlipidemia may cause a dysregulation of the cellular and local cytokine response to periodontitis (AP). The objective of the present study was to determine if diabetes has a similar dysregulatory effect on the gingival response to AP in humans. Methods: Peripheral blood, as well as gingival tissue (GT) and gingival crevicular fluid (GCF), was obtained from a total of 35 patients who were categorized into the following groups based on level of diabetic (type 2) control and presence or absence of adult periodontitis (AP): group 1, systemically and periodontally healthy (n = 6); group 2, systemically healthy with adult periodontitis (n = 7); group 3, wellcontrolled diabetes and periodontally healthy (n = 6); group 4, well‐controlled diabetes with adult periodontitis (n = 5); group 5, poorly controlled diabetes and periodontally healthy (n = 5); group 6, poorly controlled diabetes and adult periodontitis (n = 6). All subjects were given a thorough periodontal examination, including probing depths (PD), clinical attachment levels (CAL), gingival index (GI), plaque index PI), and vertical bitewing radiographs. Blood studies included levels of glycated hemoglobin (HbA1c), triglycerides (TG), cholesterol (CHL), low‐density lipoproteins (LDL), and high‐density lipoproteins (HDL). The levels of interleukin‐1 beta (IL‐1β) in GCF and GT, interleukin‐6 (IL‐6), and platelet‐derived growth factor AB (PDGF‐AB) in GT from patients in each experimental group were analyzed by enzyme‐linked immunosorbent assay (ELISA).Results: Our results indicate that all clinical indices except PI were significantly elevated in the poorly controlled and well‐controlled diabetics, compared to systemically healthy patients, but only in the subjects without preexisiting AP (Tukey's multiple comparisons, P P Conclusions: This confirms our earlier work in the diabetic rat model. These studies indicate that decreased metabolic control in type 2 diabetics results in increased serum triglycerides and has a negative influence on all clinical measures of periodontal health, particularly in patients without preexisting periodontitis. Levels of the cytokine IL‐1β showed a trend for increasing as diabetic control diminished. In contrast, levels of the growth factor PDGF, which normally increase in periodontitis, decreased in poorly controlled diabetics with periodontitis. These studies suggest a possible dysregulation of the normal cytokine/growth factor signaling axis in poorly controlled type 2 diabetics that may contribute to periodontal breakdown/diminished repair. J Periodontol 1999;70:1313‐1321
- 1 November 1999
- Published by Wiley in Journal of Periodontology
- Vol. 70 (11) , 1313-1321
Heightened Gingival Inflammation and Attachment Loss in Type 2 Diabetics With Hyperlipidemia
Background: Our previous studies in diabetic (DB) rats suggest that hyperlipidemia may cause a dysregulation of the cellular and local cytokine response to periodontitis (AP). The objective of the present study was to determine if diabetes has a similar dysregulatory effect on the gingival response to AP in humans. Methods: Peripheral blood, as well as gingival tissue (GT) and gingival crevicular fluid (GCF), was obtained from a total of 35 patients who were categorized into the following groups based on level of diabetic (type 2) control and presence or absence of adult periodontitis (AP): group 1, systemically and periodontally healthy (n = 6); group 2, systemically healthy with adult periodontitis (n = 7); group 3, wellcontrolled diabetes and periodontally healthy (n = 6); group 4, well‐controlled diabetes with adult periodontitis (n = 5); group 5, poorly controlled diabetes and periodontally healthy (n = 5); group 6, poorly controlled diabetes and adult periodontitis (n = 6). All subjects were given a thorough periodontal examination, including probing depths (PD), clinical attachment levels (CAL), gingival index (GI), plaque index PI), and vertical bitewing radiographs. Blood studies included levels of glycated hemoglobin (HbA1c), triglycerides (TG), cholesterol (CHL), low‐density lipoproteins (LDL), and high‐density lipoproteins (HDL). The levels of interleukin‐1 beta (IL‐1β) in GCF and GT, interleukin‐6 (IL‐6), and platelet‐derived growth factor AB (PDGF‐AB) in GT from patients in each experimental group were analyzed by enzyme‐linked immunosorbent assay (ELISA).Results: Our results indicate that all clinical indices except PI were significantly elevated in the poorly controlled and well‐controlled diabetics, compared to systemically healthy patients, but only in the subjects without preexisiting AP (Tukey's multiple comparisons, P P Conclusions: This confirms our earlier work in the diabetic rat model. These studies indicate that decreased metabolic control in type 2 diabetics results in increased serum triglycerides and has a negative influence on all clinical measures of periodontal health, particularly in patients without preexisting periodontitis. Levels of the cytokine IL‐1β showed a trend for increasing as diabetic control diminished. In contrast, levels of the growth factor PDGF, which normally increase in periodontitis, decreased in poorly controlled diabetics with periodontitis. These studies suggest a possible dysregulation of the normal cytokine/growth factor signaling axis in poorly controlled type 2 diabetics that may contribute to periodontal breakdown/diminished repair. J Periodontol 1999;70:1313‐1321